BIOTRICITY, INC.

Analyst Reco. Biotricity, Inc.

Equities

BTCY

US09074H2031

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-03 EDT			5-day change	1st Jan Change
1.25 ^USD	-4.01%		-2.34%	+8.70%

04-26	Biotricity Inc. Announces High Demand for Its Latest Device, Biotres Pro	CI
04-19	Top Premarket Decliners	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Downgrades Biotricity to Neutral From Buy	11-20	MT
HC Wainwright Adjusts Biotricity Price Target to $4 From $12 After 1-for-6 Reverse Stock Split, Maintains Buy Rating	23-07-07	MT
HC Wainwright Adjusts Biotricity Price Target to $4 From $12, Maintains Buy Rating	23-07-05	MT
Biotricity Exceeds $10 Million in Annual Revenue Run Rate	22-11-21	MT
Maxim Downgrades Biotricity to Hold From Buy	22-07-15	MT
Lake Street Adjusts Biotricity Price Target to $4 From $5, Maintains Buy Rating	22-07-15	MT
HC Wainwright Adjusts Biotricity's Price Target to $2 from $6, Keeps Buy Rating	22-07-15	MT
Lake Street Starts Biotricity at Buy With $5 Price Target	22-03-07	MT
HC Wainwright Starts Biotricity at Buy With $6 Price Target	21-11-23	MT
Biotricity Extends Heart Rate Variability Research to Include Fetal and Maternal Applications	18-10-23	CI
Rockyview General Hospital Leverages biotricity’s Remote Monitoring Technology to Track Heart Rate Variability and Predict Health Outcomes	16-03-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer